Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

authID Inc. Director's Dealing 2021

May 7, 2021

34633_dirs_2021-05-07_7a1bc99e-965d-4757-a11b-baf9c2eb4a82.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Ipsidy Inc. (IDTY)
CIK: 0001534154
Period of Report: 2021-05-05

Reporting Person: Broenniman Philip R (Director, President/COO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-05-05 Stock Options $0.24 A 17662313 Acquired 2031-05-05 Common Stock, $0.0001 par value per share (17662313) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock, $.0001 par value 5182412 Direct
Common Stock, $.0001 par value 9153969 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Warrants $0.15 2022-06-30 Common Stock, $0.0001 par value per share (929167) 929167 Indirect
Stock Options $0.07 2025-05-22 Common Stock, $0.0001 par value per share (16666666) 16666666 Direct
Warrants $0.165 2023-08-15 Common Stock, $0.0001 par value per share (350000) 350000 Direct
Warrants $0.088 2024-06-23 Common Stock, $0.0001 par value per share (262500) 262500 Direct

Footnotes

F1: Includes the right to acquire 1,500,000 shares of common stock at par value subject to the certain vesting criteria granted to Mr. Broenniman on March 6, 2020 pursuant to a Restricted Stock Purchase Agreement.

F2: Mr. Broenniman is the Managing Partner of Varana Capital, LLC ("Varana Capital"), which, in turn, is the investment manager of and has dispositive control over the shares held by Varana Capital Focused, LP ("VCFLP"). By virtue of these relationships, in addition to the shares he holds personally, Mr. Broenniman may be deemed to beneficially own the shares held by Varana Capital Focused, LP.

F3: On May 22, 2020, the Company granted Mr. Broenniman a Non-Statutory Option to acquire 16,666,666 shares of common stock at an exercise price of $0.07 per share with 3,333,333 shares vesting upon the grant of Non-Statutory Option, 5,333,333 shares vesting upon achieving certain performance conditions and 8,000,000 shares vesting upon achieving certain additional performance conditions.

F4: On May 5, 2021, the Company granted Mr. Broenniman a Non-Statutory Option to acquire 17,662,313 shares of common stock at an exercise price of $0.24 per share with 162,313 shares vesting upon grant of Non-Statutory Option and 17,500,000 shares of common stock underlying the stock options vesting subject to various performance conditions.